Clinical trial results show weight loss drug reduces the risk of heart and liver diseases in people with obesity
By AJ Hostetler A brand new evaluation of a big worldwide scientific trial finds semaglutide, a compound discovered in weight loss medicines Wegovy and Ozempic, reduces main heart occasions and lowers fatty liver illness risk in adults with each obesity and heart illness. People with obesity face the next risk of heart assaults and strokes….